Department of Clinical Laboratory Medicine, Shiga University of Medical Science, Shiga, Japan.
PLoS One. 2012;7(3):e32052. doi: 10.1371/journal.pone.0032052. Epub 2012 Mar 1.
RB1-inducible coiled-coil 1 (RB1CC1; also known as FIP200) plays important roles in several biological pathways such as cell proliferation and autophagy. Evaluation of RB1CC1 expression can provide useful clinical information on various cancers and neurodegenerative diseases. In order to realize the clinical applications, it is necessary to establish a stable supply of antibody and reproducible procedures for the laboratory examinations. In the present study, we have generated mouse monoclonal antibodies for RB1CC1, and four kinds of antibodies (N1-8, N1-216, N3-2, and N3-42) were found to be optimal for clinical applications such as ELISA and immunoblots and work as well as the pre-existing polyclonal antibodies. N1-8 monoclonal antibody provided the best recognition of RB1CC1 in the clinico-pathological examination of formalin-fixed paraffin-embedded tissues. These monoclonal antibodies will help to generate new opportunities in scientific examinations in biology and clinical medicine.
RB1 诱导卷曲螺旋蛋白 1(RB1CC1;也称为 FIP200)在细胞增殖和自噬等多种生物途径中发挥重要作用。评估 RB1CC1 的表达可以为各种癌症和神经退行性疾病提供有用的临床信息。为了实现临床应用,有必要建立稳定的抗体供应和用于实验室检查的可重复程序。在本研究中,我们针对 RB1CC1 生成了小鼠单克隆抗体,发现其中 4 种抗体(N1-8、N1-216、N3-2 和 N3-42)非常适合 ELISA 和免疫印迹等临床应用,与现有的多克隆抗体效果相当。N1-8 单克隆抗体在福尔马林固定石蜡包埋组织的临床病理检查中提供了对 RB1CC1 的最佳识别。这些单克隆抗体将有助于在生物学和临床医学的科学检查中带来新的机会。